PhRMA's 2012 Annual Meeting - Making Medicines Do More

PhRMA's 2012 Annual Meeting - Making Medicines Do More

03.27.12 | By

PhRMA's 2012 annual meeting will take place in Boston, a city that many leading biopharmaceutical research companies call home. In many ways, the Greater Boston area is an important hub of biopharmaceutical innovation and considered the center of many collaborative partnerships between industry and academic institutions.

We couldn't have picked a better place to gather and discuss all of the opportunities and challenges the industry faces as the health care and innovation landscape continues to evolve.

But this meeting is more than just providing a snapshot of how the biopharmaceutical industry will be tackling complex business and R&D challenges in 2012 and beyond. This year's annual meeting will tell a compelling and cohesive narrative under the overarching theme of "Making Medicines Do More" for patient health, innovation and collaboration, the state of U.S. health care system, and emerging markets.

All of these issues, and many more, will be examined by leading economists, patient groups, government officials, industry representatives and other key health care stakeholders.

Importantly, this meeting will be one of the most transparent meetings PhRMA has ever held. We're making the sessions and speeches available for viewing by the public in real time. We're also urging the public to weigh in on all the annual meeting discussions through social media platforms such as Twitter, Facebook and our own blog The Catalyst.

We believe it is important for everyone to be part of the dialogue because all of us are in some shape, form or fashion a part of the health care equation.

As the date of the annual meeting nears (April 11 to April 13) we'll be highlighting diverse voices and perspectives on The Catalyst that will provide even greater insight into the many issues and themes that will be discussed. So stay tuned!!

In the meantime, is there a particular topic you are looking forward to hearing about the most at our annual meeting?

More On PhRMA — powered by PhRMApedia


Cost in Context